Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stable isotope labeling kinetics in normal pressure hydrocephalus
2019-004664-22Phase 4Terminated
- Sponsor
- Kuopio University Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of 13C6 leucine in Idiopathic Normal Pressure Hydrocephalus (NPH) (2 arms), sponsored by Kuopio University Hospital. Primary endpoint: End of sampling. Started Apr 2020; status: terminated.
02
Drugs
13C6 leucine
03
Conditions
Idiopathic Normal Pressure Hydrocephalus (NPH)
Beyond the preview
Go deeper on 2019-004664-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004664-22.